Gadi Riesenfeld
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Gadi Riesenfeld was the founder of Otic Pharma Ltd., founded in 2008, and served as Chairman from 2011 to 2012.
Dr. Riesenfeld is currently Chairman & Chief Executive Officer at Timestamp Ltd. since 2017.
Former jobs include President & Managing Director at Kamapharm Ltd. from 1990 to 1991, Independent Director at NurExone Biologic, Inc. from 2023 to 2026, President & Managing Director at Galisar Ltd. from 1986 to 1988, President & Chief Operating Officer at W World Corp.
from 1992 to 2005, and President at W World Corp.
from 1992 to 2006.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-18 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
Timestamp Ltd. | Chief Executive Officer | 2016-12-31 |
| Companies | Position | End |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Director/Board Member | 2026-01-29 |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Founder | 2011-12-31 |
| W WORL | President | 2005-12-31 |
| W WORL | President | 2005-10-31 |
Kamapharm Ltd. | Chief Executive Officer | 1991-04-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
W World Corp.
W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Kamapharm Ltd. | |
Galisar Ltd. | |
Timestamp Ltd. | |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Select your edition
All financial news and data tailored to specific country editions